DISIALYLLACTO-N-TETRAOSE
UNII 9CM5FJZ8AR

Substance Identification & Data

This profile provides standardized clinical and technical data for Disialyllacto-n-tetraose, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9CM5FJZ8AR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 61278-38-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9CM5FJZ8AR

CAS Registry Number

61278-38-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DISIALYLLACTO-N-TETRAOSE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C48H79N3O37

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BTDPEAPRLHRFIA-VYZFFVDYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

102408290

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O([C@@]1(C(=O)O)O[C@@]([C@@H]([C@@H](CO)O)O)([C@H](NC(C)=O)[C@@H](O)C1)[H])[C@@H]2[C@@H](O)[C@](O[C@@H]3[C@@H](NC(C)=O)[C@](O[C@@H]4[C@@H](O)[C@](O[C@@H]([C@@H]([C@H](C=O)O)O)[C@@H](CO)O)(O[C@H](CO)[C@@H]4O)[H])(O[C@H](CO[C@@]5(C(O)=O)O[C@@]([C@@H]([C@@H](CO)O)O)([C@H](NC(C)=O)[C@@H](O)C5)[H])[C@H]3O)[H])(O[C@H](CO)[C@@H]2O)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Disialyllacto-n-tetraose. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

DI-N-ACETYLNEURAMINOSYLLACTO-N-TETRAOSE

DISIALYLLACTO-N-TETRAOSE

Systematic Nomenclature

(2R,4S,5R,6R)-2-(((2R,3S,4R,5R,6S)-4-(((2R,3R,4S,5S,6R)-4-(((2S,4S,5R,6R)-2-CARBOXY-5-ACETAMIDO-4-HYDROXY-6-((1R,2R)-1,2,3-TRIHYDROXYPROPYL)OXAN-2-YL)OXY)-3,5-DIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL)OXY)-6-(((2R,3S,4S,5R,6S)-3,5-DIHYDROXY-2-(HYDROXYMETHYL)-6-(((2R,3R,4R,5R)-1,2,4,5-TETRAHYDROXY-6-OXOHEXAN-3-YL)OXY)OXAN-4-YL)OXY)-5-ACETAMIDO-3-HYDROXYOXAN-2-YL)METHOXY)-5-ACETAMIDO-4-HYDROXY-6-((1R,2R)-1,2,3-TRIHYDROXYPROPYL)OXANE-2-CARBOXYLIC ACID

SYS

D-GLUCOSE, O-(N-ACETYL-.ALPHA.-NEURAMINOSYL)-(2->6)-O-(O-(N-ACETYL-.ALPHA.-NEURAMINOSYL)-(2->3)-.BETA.-D-GALACTOPYRANOSYL-(1->3))-O-2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GLUCOPYRANOSYL-(1->3)-O-.BETA.-D-GALACTOPYRANOSYL-(1->4)-

SYS

External Clinical & Regulatory Resources

Previous UNII9CLV70W7HS

Next UNII9CMB2A64PT